avid radiopharmaceuticals american company founded dr daniel skovronsky based university city science center research campus philadelphia pennsylvania company developed radioactive tracer called florbetapir florbetapir used detect beta amyloid plaques patients memory problems using positron emission tomography pet scans making company first bring market fdaapproved method directly detect hallmark pathology alzheimers disease eli lilly company announced november would acquire avid million million paid front balance paid later since disease first described alois alzheimer certain way determine person indeed disease perform autopsy patients brain find distinctive spots brain show buildup amyloid plaque doctors must diagnose disease patients memory loss dementia based symptoms many patients diagnosed disease found examination brain following death condition diagnostic tools analysis cerebrospinal fluid magnetic resonance imaging scans looking brain shrinkage pet scans looking glucose used brain avid built research done william klunk chester mathis developed substance called pittsburgh compound b means detecting amyloid plaque analyzing prospective compounds developing variations substance discovered might work study performed sweden alzheimers patients able detect plaque pet brain scans later studies control group member without disease find plaque confirming reliability compound diagnosis tool worked pittsburgh compound b relies use radioactive isotope halflife minutes requires immediate use material prepared dr skovronsky established avid radiopharmaceuticals july goal finding dye could injected body would cross barrier attach amyloid protein deposits firm raised bioadvance biotechnology greenhouse southeastern pennsylvania seed found candidate dye attached positronemitting radioactive isotope halflife nearly two hours used annually two million pet scans last long day prepared morning cyclotron dye developed patented university pennsylvania licensed initial tests patient johns hopkins university hospital previously diagnosed symptoms alzheimers disease detected plaque pet scan areas typically found brain tests found scans detected plaque patients alzheimers didnt find without diagnosis found intermediate amounts patients early signs dementia tests found amyloid plaque test patients age normal range performed worse control group tests mental order confirm dye accurate detecting alzheimers advisory committee food drug administration demanded team avid bayer general electric perform study test method avid established study group hospice patients diagnosed dementia others memory problems participants families agreed would undergo pet scans would brains autopsied death pathologists study conducted avid received confirmation may results test successful distinguishing alzheimers without results presented july international conference alzheimers disease held hawaii company showed hospice patients scanned initial scan results confirmed pathologists counted plaque microscope computerized scan plaque performed material autopsied findings require review fda confirm reliability means diagnosing disease confirmed technique would provide means reliably diagnose monitor progress alzheimers would allow potential pharmaceutical treatments study published january journal american medical association avid reported results studies conducted based test subjects agreed receive companys pet scans brains analyzed death definitive determination presence amyloid plaques patients included study died autopsies performed brains one brain autopsy results matched diagnosis based pet scan taken death avids technique used test efficacy alzheimers disease treatments developed pharmaceutical firms means determining ability drugs reduce buildup amyloid protein brains living january fda advisory committee unanimously recommended avids pet scan technique approved use advisory committee included qualification requiring firm develop clear guidelines establishing tests spotted enough amyloid plaque order make diagnosis alzheimers task avid ceo skovronsky stated could resolved several update avid sponsoring clinical trials identify subjects dopaminergic httpsenwikipediaorgwikiavidradiopharmaceuticals